MENU
GYRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Gyre Therapeutics (GYRE) Ownership - Who owns Gyre Therapeutics?
Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis... Show more
Profile
Industry
N/A
Address
12770 High Bluff Drive
Phone
+1 619 949-3681
Employees
4
Web
https://www.gyretx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
915.37M
P/E Ratio
519.50
Total Cash
26.67M
Projected Growth
N/A
Total Debt
1.6M
Revenue
105.76M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.30
Total Debt/Equity
N/A
Revenue/Share
0.99 USD as % of share price
Fundamentals
GYRE
Capitalization
915M
P/E Ratio
519.50
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
26.7M
Total Cash/Share
0.30
Total Debt
1.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.99%
Revenue
106M
ROE
N/A
Book Value
63.3M
P/B Ratio
13.44
Cash Flow
N/A
Earnings
0.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
86K
Current Ratio
3.32
Current Revenue Per Employee
48557.49
Dividends Per Share - Security
N/A
EBITDA
17.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.78
Revenue To Assets
9.99
Shares Held By Institutions
31M
Shares Outstanding - Current
88.1M
Total Liabilities
27M
Total Volume MTD
N/A
Value
-1
Gain YTD
-4.959
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
12770 High Bluff Drive
Phone
+1 619 949-3681
Employees
4
Web
https://www.gyretx.com